# Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

> **NCT00066248** · PHASE2 · COMPLETED · sponsor: **University of South Florida** · enrollment: 70 (actual)

## Conditions studied

- Brain Tumor
- Central Nervous System Tumors
- Cachexia
- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cyproheptadine hydrochloride
- **DRUG:** megestrol acetate

## Key facts

- **NCT ID:** NCT00066248
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066248, "Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00066248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*